Showing 1 - 11 results of 11 for search 'Wenzhi Tian', query time: 0.05s
Refine Results
-
1
-
2
How to select IgG subclasses in developing anti-tumor therapeutic antibodies by Jifeng Yu, Yongping Song, Wenzhi Tian
Published 2020-05-01
Article -
3
Targeting CD47 for cancer immunotherapy by Zhongxing Jiang, Hao Sun, Jifeng Yu, Wenzhi Tian, Yongping Song
Published 2021-10-01
Article -
4
-
5
Engineering approaches to manipulate osteoclast behavior for bone regeneration by Xin Cheng, Wenzhi Tian, Jianhua Yang, Jiamian Wang, Yang Zhang
Published 2024-06-01
Article -
6
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling by Song Li, Dianze Chen, Huiqin Guo, Dandan Liu, Chunmei Yang, Ruliang Zhang, Tianxiang Wang, Fan Zhang, Xing Bai, Yanan Yang, Nana Sun, Wei Zhang, Li Zhang, Gui Zhao, Liang Peng, Xiaoping Tu, Wenzhi Tian, Wenzhi Tian
Published 2023-10-01
Article -
7
-
8
Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo by Maohua Li, Rongqing Zhao, Jianxin Chen, Wenzhi Tian, Chenxi Xia, Xudong Liu, Yingzi Li, Song Li, Hunter Sun, Tong Shen, Wenlin Ren, Le Sun
Published 2021-03-01
Article -
9
SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the “don’t eat me” signal and activating the “eat me” signal... by Jifeng Yu, Song Li, Dianze Chen, Dandan Liu, Huiqin Guo, Chunmei Yang, Wei Zhang, Li Zhang, Gui Zhao, Xiaoping Tu, Liang Peng, Sijin Liu, Xing Bai, Yongping Song, Zhongxing Jiang, Ruliang Zhang, Wenzhi Tian
Published 2022-11-01
Article -
10
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A) by Jifeng Yu, Song Li, Dianze Chen, Dandan Liu, Huiqin Guo, Chunmei Yang, Wei Zhang, Li Zhang, Gui Zhao, Xiaoping Tu, Liang Peng, Sijin Liu, Xing Bai, Yongping Song, Zhongxing Jiang, Ruliang Zhang, Wenzhi Tian
Published 2022-08-01
Article -
11
A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer by Jiayang Liu, Jiayang Liu, Zhefeng Meng, Tongyang Xu, Kudelaidi Kuerban, Kudelaidi Kuerban, Songna Wang, Songna Wang, Xuyao Zhang, Xuyao Zhang, Jiajun Fan, Jiajun Fan, Dianwen Ju, Dianwen Ju, Wenzhi Tian, Xuan Huang, Xuan Huang, Xiting Huang, Danjie Pan, Danjie Pan, Huaning Chen, Huaning Chen, Weili Zhao, Li Ye, Li Ye
Published 2022-03-01
Article